Merck, Amgen Invest In Medical Video Game Developer Akili

Akili Interactive Labs Inc., a digital medicine company, has secured an additional $11.9m funding via series B financing with backing from Merck KGaA and Amgen Inc.

Akili Interactive Labs Inc., has expanded its series B financing with an additional $11.9m from new investors Merck Ventures BV, Amsterdam, The Netherlands, a subsidiary of Merck KGAA, and Amgen Ventures, the venture arm of Amgen Inc.

Earlier this year, Akili raised $30.5m from investors including JAZZ Venture Partners, Canepa Advanced Healthcare Fund and PureTech totaling the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip